Difference between revisions of "Team:TokyoTech"

 
(63 intermediate revisions by 2 users not shown)
Line 7: Line 7:
 
<meta name="viewport" content="width=device-width, initial-scale=1">
 
<meta name="viewport" content="width=device-width, initial-scale=1">
 
<link rel="stylesheet" href="main.css">
 
<link rel="stylesheet" href="main.css">
−
<link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Poppins">
 
 
<style>
 
<style>
−
body,h1,h2,h3,h4,h5 {font-family: "Poppins", sans-serif}
+
body,h1,h2,h3,h4,h5 {font-family: "Arial", sans-serif}
 
body {font-size:16px;}
 
body {font-size:16px;}
 
.w3-half img{margin-bottom:-6px;margin-top:16px;opacity:0.8;cursor:pointer}
 
.w3-half img{margin-bottom:-6px;margin-top:16px;opacity:0.8;cursor:pointer}
Line 15: Line 14:
 
</style>
 
</style>
 
<body>
 
<body>
 +
 +
<div id="loader-bg">
 +
  <div id="loader">
 +
    <div class="photo-show">
 +
    <img src="https://static.igem.org/mediawiki/2017/f/f4/T--TokyoTech--load_1.png" width="600">
 +
    <img src="https://static.igem.org/mediawiki/2017/4/43/T--TokyoTech--load_2.png" width="600">
 +
    </div>
 +
  </div>
 +
</div>
  
 
<!-- Sidebar/menu -->
 
<!-- Sidebar/menu -->
 
<nav class="w3-sidebar w3-red w3-collapse w3-top w3-large w3-padding" style="z-index:3;width:300px;font-weight:bold;" id="mySidebar"><br>
 
<nav class="w3-sidebar w3-red w3-collapse w3-top w3-large w3-padding" style="z-index:3;width:300px;font-weight:bold;" id="mySidebar"><br>
 
   <a href="javascript:void(0)" onclick="w3_close()" class="w3-button w3-hide-large w3-display-topleft" style="width:100%;font-size:20px">Close Menu</a>
 
   <a href="javascript:void(0)" onclick="w3_close()" class="w3-button w3-hide-large w3-display-topleft" style="width:100%;font-size:20px">Close Menu</a>
−
   <div class="w3-container" style="margin-top: 20px;margin-bottom: 25px">
+
   <div class="w3-container" style="margin-top: 20px;margin-bottom: 25px" id="wrap">
 
     <img src="https://static.igem.org/mediawiki/2017/a/a8/T--TokyoTech--logo_white_bright_10211603.png" style="width: 100%">
 
     <img src="https://static.igem.org/mediawiki/2017/a/a8/T--TokyoTech--logo_white_bright_10211603.png" style="width: 100%">
 
   </div>
 
   </div>
  
−
   <div style="padding-top: 15px; padding-left: 25px;">
+
   <div style="padding-top: 15px; padding-left: 25px; id="wrap">
  
 
   <div id="contents" style="z-index: 10">
 
   <div id="contents" style="z-index: 10">
Line 50: Line 58:
 
     <label for="vmcb-d"><a>Experiment</a></label>
 
     <label for="vmcb-d"><a>Experiment</a></label>
 
     <ul>
 
     <ul>
−
         <li style="padding-bottom: 10px; padding-top: 10px">
+
 
 +
         <li>
 
         <input type="checkbox" id="vmcb-d1" />
 
         <input type="checkbox" id="vmcb-d1" />
−
          <label for="vmcb-d1"><a style="text-align: center;">Bacteria <br>to Human Cells ▼</a></label>
+
        <label for="vmcb-d1"><a href="https://2017.igem.org/Team:TokyoTech/Experiment/Overview" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white" style="text-align: center;">Overview</a></label>
 +
        </li>
 +
 
 +
        <li style="padding-bottom: 10px; padding-top: 5px">
 +
        <input type="checkbox" id="vmcb-d2" />
 +
          <label for="vmcb-d2"><a style="text-align: center;">Bacteria to <br>Human Cells ▼</a></label>
 
             <ul>
 
             <ul>
 
               <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Experiment/TraI_Assay" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">TraI Assay</a></li>
 
               <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Experiment/TraI_Assay" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">TraI Assay</a></li>
−
               <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Experiment/TraI_Improvement" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">TraI Impovement <br>Assay</a></li>
+
               <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Experiment/TraI_Improvement" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">TraI Improvement <br>Assay</a></li>
−
               <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Experiment/TraR_Reporter_Assay" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white" >TraR Reporter <br> Assay</a></li>
+
               <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Experiment/TraR_Reporter_Assay" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white" >TraR Reporter <br>Assay</a></li>
−
               <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Experiment/Transcriptome_Analysis" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Transcriptome <br> Analysis</a></li>
+
               <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Experiment/Transcriptome_Analysis" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Transcriptome <br>Analysis</a></li>
 
               <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Experiment/Chimeric_Transcription_Factor" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Chimeric <br> Transcription <br> Factor Assay</a></li>
 
               <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Experiment/Chimeric_Transcription_Factor" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Chimeric <br> Transcription <br> Factor Assay</a></li>
 
             </ul>
 
             </ul>
 
       </li>
 
       </li>
  
−
       <li style="padding-bottom: 10px">
+
       <li style="padding-bottom: 3px">
−
       <input type="checkbox" id="vmcb-d2" />
+
       <input type="checkbox" id="vmcb-d3" />
−
     <label for="vmcb-d2"><a style="text-align: center;">Human Cells to Bacteria ▼</a></label>
+
     <label for="vmcb-d3"><a style="text-align: center;">Human Cells to <br>Bacteria ▼</a></label>
 
         <ul>
 
         <ul>
 
           <li><a href="https://2017.igem.org/Team:TokyoTech/Experiment/AHK4_Assay" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">AHK4 Assay</a></li>
 
           <li><a href="https://2017.igem.org/Team:TokyoTech/Experiment/AHK4_Assay" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">AHK4 Assay</a></li>
Line 70: Line 84:
 
         </li>
 
         </li>
  
−
         <li style="padding-bottom: 10px">
+
         <li>
−
         <input type="checkbox" id="vmcb-d3" />
+
         <input type="checkbox" id="vmcb-d4" />
−
     <label for="vmcb-d3"><a href="https://2017.igem.org/Team:TokyoTech/InterLab" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white" style="text-align: center;">InterLab</a></label>
+
     <label for="vmcb-d4"><a href="https://2017.igem.org/Team:TokyoTech/InterLab" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white" style="text-align: center;">InterLab</a></label>
 
         </li>
 
         </li>
 
     </ul>
 
     </ul>
Line 89: Line 103:
 
     <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/HP" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Overview</a></li>
 
     <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/HP" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Overview</a></li>
 
     <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/HP/Silver" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Silver</a></li>
 
     <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/HP/Silver" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Silver</a></li>
−
     <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/HP/Gold_Integrated" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Integrated <br> Human Practice</a></li>
+
     <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/HP/Gold_Integrated" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Gold (Integrated)</a></li>
 
     <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Demonstrate" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Demonstrate</a></li>
 
     <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Demonstrate" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Demonstrate</a></li>
 
     <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Collaborations" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Collaborations</a></li>
 
     <li style="text-align: center;"><a href="https://2017.igem.org/Team:TokyoTech/Collaborations" onclick="w3_close()" class="w3-bar-item w3-button w3-hover-white">Collaborations</a></li>
Line 120: Line 134:
  
 
<!-- PAGE CONTENT! -->
 
<!-- PAGE CONTENT! -->
−
<div class="w3-main" style="margin-left:340px;margin-right:40px">
+
<div class="w3-main" style="margin-left:340px;margin-right:40px" id="wrap">
 +
 
 
  <div class="w3-container" id="overview" style="margin-top:20px">
 
  <div class="w3-container" id="overview" style="margin-top:20px">
 
<div class="photo-show" style="padding-bottom: 20%">
 
<div class="photo-show" style="padding-bottom: 20%">
 
      
 
      
−
<img src="https://static.igem.org/mediawiki/2017/d/d8/T--TokyoTech--slideshow1_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/1/14/T--TokyoTech--slideshow_no.2_2.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/c/c4/T--TokyoTech--slideshow2_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/9/95/T--TokyoTech--slideshow_no.2_1.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/c/cc/T--TokyoTech--slideshow4_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/4/4d/T--TokyoTech--slideshow_no.2_3.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/d/d8/T--TokyoTech--slideshow1_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/1/14/T--TokyoTech--slideshow_no.2_2.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/c/c4/T--TokyoTech--slideshow2_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/9/95/T--TokyoTech--slideshow_no.2_1.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/c/cc/T--TokyoTech--slideshow4_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/4/4d/T--TokyoTech--slideshow_no.2_3.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/d/d8/T--TokyoTech--slideshow1_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/1/14/T--TokyoTech--slideshow_no.2_2.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/c/c4/T--TokyoTech--slideshow2_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/9/95/T--TokyoTech--slideshow_no.2_1.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/c/cc/T--TokyoTech--slideshow4_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/4/4d/T--TokyoTech--slideshow_no.2_3.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/d/d8/T--TokyoTech--slideshow1_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/1/14/T--TokyoTech--slideshow_no.2_2.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/c/c4/T--TokyoTech--slideshow2_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/9/95/T--TokyoTech--slideshow_no.2_1.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/c/cc/T--TokyoTech--slideshow4_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/4/4d/T--TokyoTech--slideshow_no.2_3.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/d/d8/T--TokyoTech--slideshow1_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/1/14/T--TokyoTech--slideshow_no.2_2.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/c/c4/T--TokyoTech--slideshow2_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/9/95/T--TokyoTech--slideshow_no.2_1.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/c/cc/T--TokyoTech--slideshow4_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/4/4d/T--TokyoTech--slideshow_no.2_3.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/d/d8/T--TokyoTech--slideshow1_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/1/14/T--TokyoTech--slideshow_no.2_2.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/c/c4/T--TokyoTech--slideshow2_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/9/95/T--TokyoTech--slideshow_no.2_1.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/c/cc/T--TokyoTech--slideshow4_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/4/4d/T--TokyoTech--slideshow_no.2_3.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/d/d8/T--TokyoTech--slideshow1_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/1/14/T--TokyoTech--slideshow_no.2_2.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/c/c4/T--TokyoTech--slideshow2_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/9/95/T--TokyoTech--slideshow_no.2_1.jpg">
−
<img src="https://static.igem.org/mediawiki/2017/c/cc/T--TokyoTech--slideshow4_r.jpg">
+
<img src="https://static.igem.org/mediawiki/2017/4/4d/T--TokyoTech--slideshow_no.2_3.jpg">
 
</div><!--aspslide-->
 
</div><!--aspslide-->
 +
</div>
 +
 +
<div class="w3-container" id="overview" style="padding-top:20%;padding-bottom: 15px;text-align: center;">
 +
<center><hr style="width:300px;border:3px solid red;" class="w3-round"></center>
 
</div>
 
</div>
  
 
   <!-- Overview -->
 
   <!-- Overview -->
−
   <div class="w3-container" id="overview" style="margin-top:20px">
+
   <div class="w3-container" id="overview" style="padding-top:5px;padding-bottom: 5px;text-align: center;">
−
    <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Overview</b></h1>
+
     <h4 style="text-indent: 1em;color: #4a0f0c">Do you want to photosynthesize or fix nitrogen by yourself?</h4>
−
     <hr style="width:50px;border:5px solid red" class="w3-round">
+
     <h4 style="text-indent: 1em;color: #4a0f0c">
−
     <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
+
    If one-time cancer treatment lasts forever, don't you think it's amazing?</h4>
−
    </p>
+
</div>
−
  </div>
+
  
−
<img src="https://static.igem.org/mediawiki/2017/d/da/T--TokyoTech--ribbon_hr.png" alt="John" style="width:95%">
+
<div class="w3-container" id="overview" style="padding-top:5px;padding-bottom: 5px;text-align: center;">
 +
<center><hr style="width:300px;border:3px solid red" class="w3-round"></center>
 +
</div>
  
 +
<div class="w3-container" id="overview" style="padding-top:15px;padding-bottom: 15px;text-align: center;color: #4a0f0c">
 +
    <p style="text-indent: 1em;font-size: 18px;padding-top: 15px">
 +
    If you could co-exist with bacteria, you could be a super human. We named this new type of human 'Coli Sapiens.' Currently, however, there's no way to co-culture bacteria and human cells under <span style="font-style: italic;">in vitro</span> conditions. If you'd like to co-culture them <b>artificially</b>, you have to clear two tasks below.</p>
 +
</div>
  
−
<!-- Project -->
+
<div class="w3-container" id="overview" style="padding-top:15px;padding-bottom: 15px;text-align: center;color: #4a0f0c;border: 5px">
−
    <div class="w3-container" id="project" style="margin-top:20px">
+
<center>
−
    <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Project  </b><a href="https://2017.igem.org/Team:TokyoTech/Project"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></a></h1>
+
<h4 style="text-indent: 1em;color: #4a0f0c">
−
    <hr style="width:50px;border:5px solid red" class="w3-round">
+
1. Establishing a cross-kingdom talk between human cells and bacteria</h4>
−
    <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
+
<h4 style="text-indent: 1em;color: #4a0f0c">
−
    </p>
+
2. Sustaining the balance between human cells and bacteria</h4>
−
  </div>
+
</center>
 +
</div>
  
−
  <hr>
+
<center>
 +
<div class="w3-container" id="overview" style="padding-top:15px;padding-bottom: 15px;text-align: center;color: #4a0f0c;border: 5px">
  
−
  <!-- Modeling -->
+
<p style="font-size:18px;text-align:center">
−
    <div class="w3-container" id="modeling" style="margin-top:20px">
+
To clear these tasks, we tried to establish a cross-kingdom talk and creating a co-culture model.</p>
−
    <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Modeling  </b><a href="https://2017.igem.org/Team:TokyoTech/Modeling"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></a></h1>
+
−
    <hr style="width:50px;border:5px solid red" class="w3-round">
+
−
    <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
+
−
    </p>
+
−
  </div>
+
  
−
  <hr>
+
</div>
 +
</center>
 +
<hr>
  
−
  <!-- Human Practice -->
+
   <div class="scale" id="overview" style="margin-top:10px;text-align: center;">
−
   <div class="w3-container" id="hp" style="margin-top:20px">
+
    <img src="https://static.igem.org/mediawiki/2017/4/40/Top_image12.png" alt="John" style="width:80%">
−
    <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Human Practices  </b><a href="https://2017.igem.org/Team:TokyoTech/Human_Practices"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></h1>
+
−
    <hr style="width:50px;border:5px solid red" class="w3-round">
+
−
    <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
+
−
    </p>
+
 
   </div>
 
   </div>
  
−
  <hr>
+
<hr>
  
−
  <!-- Notebook -->
+
<div class="w3-container" id="contact" style="margin-top:20px">
−
    <div class="w3-container" id="notebook" style="margin-top:20px">
+
     <p style="font-size: 18px;text-indent: 1em">In a real world, multiple kinds of organisms co-exist and the ecosystem is sustained by their mutual dependence. However, in iGEM community, it's been a standard to use single organism in project and it's not an overstatement that most teams don't take it into account. Therefore, to target "true human organism", it's necessary to establish the system that human cells and bacteria co-exist under <span style="font-style: italic;">in vitro</span> conditions. Our co-culture system will be a big progress for iGEM and synthetic biology.
−
     <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Notebook  </b><a href="https://2017.igem.org/Team:TokyoTech/Notebook"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></a></h1>
+
−
    <hr style="width:50px;border:5px solid red" class="w3-round">
+
−
    <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
+
 
     </p>
 
     </p>
 
   </div>
 
   </div>
Line 199: Line 215:
 
   <hr>
 
   <hr>
  
−
  <!-- Team -->
 
−
    <div class="w3-container" id="team" style="margin-top:20px">
 
−
    <h1 class="w3-xxxlarge w3-text-red" style="padding-bottom: 10px;padding-top: 10px"><b>Team  </b><a href="https://2017.igem.org/Team:TokyoTech/Team"><button class="w3-button w3-red w3-padding-large w3-hover-black" style="font-size: 25px">Read More</button></a></h1>
 
−
    <hr style="width:50px;border:5px solid red" class="w3-round">
 
−
    <p style="font-family: Poppins;font-size: 16px">Gene therapy has been expected in cancer therapy for years. An interesting therapy for cancer using anaerobic bacteria as a carrier has been developed, but after the anaerobic cancer region is diminished, the bacteria cannot stay there anymore. If anti-cancer bacteria can stay in affected area, they promptly respond to cancer recurrence. Co-existence of bacteria and host cells should be quite difficult in our body or human cell culture systems, because bacteria grow so fast. It is important to control bacterial proliferation in them. So, we try to establish a new living system that human cells control the population of bacteria by engineering the both cells by creating two signaling pathways of 1) Bacteria-Mammals and 2) Bacteria-Plants. We expect that this system will lead to a new experimental approach and a new medical therapy. Moreover, we imagine about "A boundary between cellular groups and living organisms" with general public.
 
−
    </p>
 
−
  </div>
 
  
−
  <hr>
+
<!-- End page content -->
 +
</div>
  
−
<!-- PAGE CONTENT! -->
+
<div class="w3-container" id="contact" style="margin-top:20px">
−
 
+
<p id="pageTop" style="text-align:right"><a href="#wrap"><img src="https://static.igem.org/mediawiki/2017/0/0d/T--TokyoTech--page_top_2.png" style="width:200px"></a></p>
−
  <div class="w3-container" id="contact" style="margin-top:75px">
+
−
    <img src="https://static.igem.org/mediawiki/2017/4/40/Top_image12.png" alt="John" style="width:100%">
+
−
  </div>
+
−
 
+
−
 
+
−
  <!-- Sponsers -->
+
−
  <div class="w3-container" id="sponsers" style="margin-top:75px;">
+
−
    <h1 class="w3-xxxlarge w3-text-red" style="padding-top: 10px;padding-bottom: 10px"><b>Sponsers</b></h1>
+
−
    <hr style="width:50px;border:5px solid red" class="w3-round">
+
−
  </div>
+
−
 
+
−
  <div class="w3-row-padding">
+
−
    <div class="w3-col m4 w3-margin-bottom">
+
−
      <div class="w3-light-grey">
+
−
        <img src="https://static.igem.org/mediawiki/2016/4/47/Tokyo_Tech_JASSO.gif" style="width:100%">
+
−
        <div class="w3-container">
+
−
          <h3>JASSO</h3>
+
−
        </div>
+
−
      </div>
+
−
    </div>
+
−
    <div class="w3-col m4 w3-margin-bottom">
+
−
      <div class="w3-light-grey">
+
−
        <img src="http://kuramae-old.tokyo.r-cms.jp/files/user/common/p_images/head_logo.gif" style="width:100%">
+
−
        <div class="w3-container">
+
−
          <h3>Kuramae Kougyoukai</h3>
+
−
        </div>
+
−
      </div>
+
−
    </div>
+
−
    <div class="w3-col m4 w3-margin-bottom">
+
−
      <div class="w3-light-grey">
+
−
        <img src="http://www.vmcs.ucdavis.edu/idt/images/idt-logo.jpg" style="width:100%">
+
−
        <div class="w3-container">
+
−
          <h3>IDT</h3>
+
−
        </div>
+
−
      </div>
+
−
    </div>
+
−
  </div>
+
−
 
+
−
<!-- End page content -->
+
 
</div>
 
</div>
  
 
<!-- W3.CSS Container -->
 
<!-- W3.CSS Container -->
−
<div class="w3-light-grey w3-container w3-padding-32" style="margin-top:75px;padding-right:58px"><p class="w3-right">Hajime Fujita:  <a href="96haji.me" title="W3.CSS" target="_blank" class="w3-hover-opacity">All Rights Reserved</a></p></div>
+
<div class="w3-light-grey w3-container w3-padding-32" style="margin-top:75px;padding-right:58px"><p class="w3-right"><a href="http://96haji.me/" title="W3.CSS" target="_blank" class="w3-hover-opacity">Hajime Fujita with W3.CSS: All Rights Reserved</a></p></div>
  
 +
<script src="http://ajax.googleapis.com/ajax/libs/jquery/1.11.1/jquery.min.js"></script>
 
<script>
 
<script>
 
// Script to open and close sidebar
 
// Script to open and close sidebar
Line 266: Line 238:
 
     document.getElementById("myOverlay").style.display = "none";
 
     document.getElementById("myOverlay").style.display = "none";
 
}
 
}
−
 
+
</script>
 +
<script>
 
// Modal Image Gallery
 
// Modal Image Gallery
 
function onClick(element) {
 
function onClick(element) {
Line 274: Line 247:
 
   captionText.innerHTML = element.alt;
 
   captionText.innerHTML = element.alt;
 
}
 
}
 +
$(function() {
 +
  var h = $(window).height();
 +
 +
  $('#wrap').css('display','none');
 +
  $('#loader-bg ,#loader').height(h).css('display','block');
 +
});
 +
 +
$(window).load(function () { //全ての読み込みが完了したら実行
 +
  $('#loader-bg').delay(900).fadeOut(800);
 +
  $('#loader').delay(600).fadeOut(300);
 +
  $('#wrap').css('display', 'block');
 +
});
 +
</script>
 +
<script>
 +
//■page topボタン
 +
$(function(){
 +
var topBtn=$('#pageTop');
 +
topBtn.hide();
 +
 +
//◇ボタンの表示設定
 +
$(window).scroll(function(){
 +
  if($(this).scrollTop()>80){
 +
    //---- 画面を80pxスクロールしたら、ボタンを表示する
 +
    topBtn.fadeIn();
 +
  }else{
 +
    //---- 画面が80pxより上なら、ボタンを表示しない
 +
    topBtn.fadeOut();
 +
  }
 +
});
 +
 +
// ◇ボタンをクリックしたら、スクロールして上に戻る
 +
topBtn.click(function(){
 +
  $('body,html').animate({
 +
  scrollTop: 0},500);
 +
  return false;
 +
});
 +
 +
});
 
</script>
 
</script>
  
 
</body>
 
</body>
 
</html>
 
</html>

Latest revision as of 02:56, 2 November 2017

<!DOCTYPE html> Coli Sapiens

iGEM Tokyo Tech

Do you want to photosynthesize or fix nitrogen by yourself?

If one-time cancer treatment lasts forever, don't you think it's amazing?

If you could co-exist with bacteria, you could be a super human. We named this new type of human 'Coli Sapiens.' Currently, however, there's no way to co-culture bacteria and human cells under in vitro conditions. If you'd like to co-culture them artificially, you have to clear two tasks below.

1. Establishing a cross-kingdom talk between human cells and bacteria

2. Sustaining the balance between human cells and bacteria

To clear these tasks, we tried to establish a cross-kingdom talk and creating a co-culture model.

John

In a real world, multiple kinds of organisms co-exist and the ecosystem is sustained by their mutual dependence. However, in iGEM community, it's been a standard to use single organism in project and it's not an overstatement that most teams don't take it into account. Therefore, to target "true human organism", it's necessary to establish the system that human cells and bacteria co-exist under in vitro conditions. Our co-culture system will be a big progress for iGEM and synthetic biology.

Hajime Fujita with W3.CSS: All Rights Reserved